The study of adipose tissue processed with the SyntrFuge™ system for diabetic foot ulcers
The company Syntr Health Technologies, Inc is enrolling patients into the clinical trial investigating Multi-Center, Randomized Controlled Clinical Investigation Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System in the Healing of Diabetic Foot Ulcers.
This is a randomized controlled multi center study on diabetic patients with the aim of evaluating the efficacy of the adipose tissue processed with the SyntrFuge™ system in diabetic patients with diabetic foot ulcers. In particular, it will be evaluated whether the microsized fat graft will be able to shorten the healing times of these wounds. Patients will be randomized to the treatment group with adipose tissue processed with the SyntrFuge™ system (injection of autologous microsized adipose tissue) or to the control group represented by the standard of care.
The trial is designed to enroll male and female 18 Years to 85 Years and is being conducted in the Roanoke, Roanoke, Virginia, United States.
The study start date is October 10, 2021.
This page provides a more detailed overview of this clinical trial: https://ichgcp.net/clinical-trials-registry/NCT05519501.
